Federal
Calling for the establishment of a new unit of the National Institutes of Health, to be known as The National Institute of Viral Diseases, to increase research in the field of viral disease causes, prevention, and treatment.
Source: Congress.gov ·
808 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IV
117TH CONGRESS
1ST SESSION
H. RES. 93
Calling for the establishment of a new unit of the National Institutes of
Health, to be known as The National Institute of Viral Diseases, to
increase research in the field of viral disease causes, prevention, and
treatment.
IN THE HOUSE OF REPRESENTATIVES
FEBRUARY 3, 2021
Ms. KAPTUR submitted the following resolution; which was referred to the
Committee on Energy and Commerce
RESOLUTION
Calling for the establishment of a new unit of the National
Institutes of Health, to be known as The National Insti-
tute of Viral Diseases, to increase research in the field
of viral disease causes, prevention, and treatment.
Whereas the pandemic caused by the severe acute respiratory
syndrome coronavirus 2 (in this preamble referred to as
‘‘COVID–19’’) is perhaps the greatest threat to the
health and prosperity of the United States since the
Great Depression, and COVID–19 has sickened more
than 26 million people in the United States, has killed
more than 440,000 people, and has left hundreds of
thousands of survivors with long-term vascular, neuro-
logical, and other complications;
VerDate Sep 11 2014
04:16 Feb 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR93.IH
HR93
dlhill on DSK120RN23PROD with BILLS
2
•HRES 93 IH
Whereas COVID–19 has exceeded 102,000,000 cases and
2,100,000 million deaths worldwide;
Whereas projections, using the optimistic assumption that
COVID–19 will be controlled by the fall of 2021 by vac-
cines still untried or fully tested, foresee economic costs
estimated at more than $16 trillion, almost 90 percent of
the annual gross domestic product of the United States;
Whereas the toll in illness, death, and direct economic dam-
age caused by COVID–19 justifies a fundamental reorga-
nization and significant expansion of the commitment of
the Federal Government to fund research on diseases
caused by viruses and their prevention and treatment;
Whereas COVID–19 is only one of more than 130 viruses
known to cause diseases in humans, these diseases sicken
millions of people in the United States each year, and
they range from relatively mild to devastating, including
the common cold, infectious diarrhea, HIV/AIDS, mea-
sles, chicken pox, hepatitis, mumps, cervical cancer, and
certain forms of leukemia;
Whereas viruses also pose serious health and economic
threats to domestic pets, farm animals, and food crops;
Whereas scientists predict that the toll from viral diseases
will increase in the future, with new disease-causing vi-
ruses spreading from animals to people due to human in-
trusion into previously wild environments, increased
international travel, and mass migrations resulting from
war, famine, and national disasters;
Whereas despite the scope and seriousness of this problem,
there is no treatment or cure for most viral infections in
humans and existing treatments can only relieve symp-
VerDate Sep 11 2014
03:19 Feb 04, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR93.IH
HR93
dlhill on DSK120RN23PROD with BILLS
3
•HRES 93 IH
toms while victims wait and hope that their immune sys-
tem will fight off the virus;
Whereas vaccines can protect people from some viral disease,
but no vaccine exists for the most common viral infec-
tions, including the common cold, and vaccines for influ-
enza provide only temporary protection and must be re-
newed annually;
Whereas viruses called bacteriophages are one of the most
promising ways of treating anti-biotic resistant bacteria,
but Federal investment in scientific research in this area
lags;
Whereas the House of Representatives recognizes the impor-
tance of biological sciences research and its contributions
to advancing medical countermeasures for the betterment
of the American public; and
Whereas the virus-related funding of the Federal Government
is fragmented, uncoordinated, and not uniquely focused
as it is allocated among multiple Federal agencies, in-
cluding the National Institute for Allergies and Infectious
Diseases, the Centers for Disease Control and Preven-
tions, the Food and Drug Administration, the Health Re-
sources and Services Administration, the United States
Agency for International Development, and the Fogarty
International Center of the National Institutes of Health:
Now, therefore, be it
Resolved, That—
1
(1) the Director of the National Institutes of
2
Health should establish a new research institute of
3
the National Institutes of Health, to be known as
4
the National Institute of Viral Diseases, to focus, co-
5
VerDate Sep 11 2014
03:19 Feb 04, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR93.IH
HR93
dlhill on DSK120RN23PROD with BILLS
4
•HRES 93 IH
ordinate, and increase research funding on the
1
causes, prevention, and treatment of diseases caused
2
by viruses; and
3
(2) all existing and future research of this kind
4
should be coordinated through the new National In-
5
stitute of Viral Diseases.
6
Æ
VerDate Sep 11 2014
03:19 Feb 04, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR93.IH
HR93
dlhill on DSK120RN23PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.